These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 8397008

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A new type of functional VIP receptor has an affinity for helodermin in human SUP-T1 lymphoblasts.
    Robberecht P, Waelbroeck M, De Neef P, Tastenoy M, Gourlet P, Cogniaux J, Christophe J.
    FEBS Lett; 1988 Feb 15; 228(2):351-5. PubMed ID: 2830146
    [Abstract] [Full Text] [Related]

  • 4. Characterization of binding sites for VIP-related peptides and activation of adenylate cyclase in developing pancreas.
    Le Meuth V, Farjaudon N, Bawab W, Chastre E, Rosselin G, Guilloteau P, Gespach C.
    Am J Physiol; 1991 Feb 15; 260(2 Pt 1):G265-74. PubMed ID: 1847591
    [Abstract] [Full Text] [Related]

  • 5. Secretin receptors in human pancreatic membranes.
    Robberecht P, De Neef P, Waelbroeck M, Camus JC, Scemama JL, Fourmy D, Pradayrol L, Vaysse N, Christophe J.
    Pancreas; 1988 Feb 15; 3(5):529-35. PubMed ID: 3186683
    [Abstract] [Full Text] [Related]

  • 6. Adenylyl cyclase stimulation by VIP in rat seminal vesicle membranes.
    Rodriguez-Pena MS, Guijarro LG, Prieto JC.
    Peptides; 1991 Feb 15; 12(4):821-4. PubMed ID: 1664946
    [Abstract] [Full Text] [Related]

  • 7. [D-Phe4]peptide histidine-isoleucinamide ([D-Phe4]PHI), a highly selective vasoactive-intestinal-peptide (VIP) agonist, discriminates VIP-preferring from secretin-preferring receptors in rat pancreatic membranes.
    Robberecht P, Coy DH, De Neef P, Camus JC, Cauvin A, Waelbroeck M, Christophe J.
    Eur J Biochem; 1987 Jun 01; 165(2):243-9. PubMed ID: 3036504
    [Abstract] [Full Text] [Related]

  • 8. Vasoactive intestinal peptide stimulation of human renal adenylate cyclase in vitro.
    Charlton BG, Neal DE, Simmons NL.
    J Physiol; 1990 Apr 01; 423():475-84. PubMed ID: 2167366
    [Abstract] [Full Text] [Related]

  • 9. Pharmacology, molecular identification and functional characteristics of vasoactive intestinal peptide receptors in human breast cancer cells.
    Gespach C, Bawab W, de Cremoux P, Calvo F.
    Cancer Res; 1988 Sep 15; 48(18):5079-83. PubMed ID: 2842044
    [Abstract] [Full Text] [Related]

  • 10. Characterization of vasoactive intestinal peptide receptors in human liver.
    Rodríguez-Henche N, Rodríguez-Pena MS, Guijarro LG, Prieto JC.
    Biochim Biophys Acta; 1994 Mar 31; 1221(2):193-8. PubMed ID: 8148398
    [Abstract] [Full Text] [Related]

  • 11. Homologous regulation of adenylate cyclase-coupled receptors for vasoactive intestinal peptide (VIP) on human mononuclear leucocytes.
    Wiik P.
    Regul Pept; 1988 Apr 31; 20(4):323-33. PubMed ID: 2835796
    [Abstract] [Full Text] [Related]

  • 12. Analysis of vasoactive intestinal peptide receptors and the G protein regulation of adenylyl cyclase in seminal vesicle membranes from streptozotocin-diabetic rats.
    Rodriguez-Pena MS, Guijarro LG, Juarranz MG, Rodriguez-Henche N, Bajo AM, Aguado F, Prieto JC.
    Cell Signal; 1994 Feb 31; 6(2):147-56. PubMed ID: 8086277
    [Abstract] [Full Text] [Related]

  • 13. Properties of vasoactive-intestinal-peptide receptors and beta-adrenoceptors in the murine radiation leukemia-virus-induced lymphoma cell line BL/VL3.
    Abello J, Damien C, De Neef P, Tastenoy M, Hooghe R, Robberecht P, Christophe J.
    Eur J Biochem; 1989 Aug 01; 183(2):263-7. PubMed ID: 2547606
    [Abstract] [Full Text] [Related]

  • 14. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
    Zawilska JB, Niewiadomski P, Nowak JZ.
    Gen Comp Endocrinol; 2004 Jun 01; 137(2):187-95. PubMed ID: 15158130
    [Abstract] [Full Text] [Related]

  • 15. Characterization of a common VIP-PACAP receptor in human small intestinal epithelium.
    Salomon R, Couvineau A, Rouyer-Fessard C, Voisin T, Lavallée D, Blais A, Darmoul D, Laburthe M.
    Am J Physiol; 1993 Feb 01; 264(2 Pt 1):E294-300. PubMed ID: 8383439
    [Abstract] [Full Text] [Related]

  • 16. Heart receptors for VIP, PHI and secretin are able to activate adenylate cyclase and to mediate inotropic and chronotropic effects. Species variations and physiopathology.
    Christophe J, Waelbroeck M, Chatelain P, Robberecht P.
    Peptides; 1984 Feb 01; 5(2):341-53. PubMed ID: 6089134
    [Abstract] [Full Text] [Related]

  • 17. Interaction of vasoactive intestinal peptide with a cell line (HeLa) derived from human carcinoma of the cervix: binding to specific sites and stimulation of adenylate cyclase.
    Prieto JC, Guerrero JM, de Miguel C, Goberna R.
    Mol Cell Biochem; 1981 Jul 01; 37(3):167-76. PubMed ID: 6268963
    [Abstract] [Full Text] [Related]

  • 18. VIP receptors in human SUP-T1 lymphoblasts.
    Christophe J, Cauvin A, Vervisch E, Buscail L, Damien C, Abello J, Gourlet P, Robberecht P.
    Digestion; 1990 Jul 01; 46 Suppl 2():148-55. PubMed ID: 1979777
    [Abstract] [Full Text] [Related]

  • 19. Vasoactive intestinal peptide (VIP) and peptide having N-terminal histidine and C-terminal isoleucine amide (PHI) stimulate adenylate cyclase activity in human heart membranes.
    Taton G, Chatelain P, Delhaye M, Camus JC, De Neef P, Waelbroeck M, Tatemoto K, Robberecht P, Christophe J.
    Peptides; 1982 Jul 01; 3(6):897-900. PubMed ID: 6897744
    [Abstract] [Full Text] [Related]

  • 20. Pharmacological characterization of the novel helodermin/VIP receptor present in human SUP-T1 lymphoma cell membranes.
    Robberecht P, De Neef P, Gourlet P, Cauvin A, Coy DH, Christophe J.
    Regul Pept; 1989 Jul 01; 26(2):117-26. PubMed ID: 2552509
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.